FDA Communications Through the Drug Development Lifecycle
As a drug makes its way through the development lifecycle, one of the most important relationships for a sponsor to
As a drug makes its way through the development lifecycle, one of the most important relationships for a sponsor to
In this increasingly digital world, we have to remember data is now available in many different medians, including paper. When we think of clinical trials and the critical data
The Call to Action Data is the most important asset for a pharmaceutical or biotechnology company to produce during clinical
Clinical development proceeds in phases, and each phase contains a set of clinical trials. These trials, including their sample size
Steps to Implementing a Quality Management System Making quality not just an expectation, but an intrinsic and foundational element of
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
This white paper promotes an end-to-end approach through discussing Organizational design, Team structure, Process design, and Talent development programs.
While enrolling subjects is arguably the most crucial aspect of clinical research operations, this cannot be done without activating a
Discover practical guidance on vendor management, including vendor selection, risk assessment, and oversight to ensure trial success.
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
This white paper outlines a data strategy specific to an organization’s unique needs and allows for adjustments as the organization grows and evolves.